Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)
36.00
+0.25 (0.70%)
At close: Dec 5, 2025
SHA:688180 Revenue
Shanghai Junshi Biosciences had revenue of 637.50M CNY in the quarter ending September 30, 2025, with 31.40% growth. This brings the company's revenue in the last twelve months to 2.48B, up 38.93% year-over-year. In the year 2024, Shanghai Junshi Biosciences had annual revenue of 1.95B with 29.67% growth.
Revenue (ttm)
2.48B
Revenue Growth
+38.93%
P/S Ratio
13.34
Revenue / Employee
963.15K
Employees
2,578
Market Cap
33.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.95B | 445.77M | 29.67% |
| Dec 31, 2023 | 1.50B | 49.06M | 3.38% |
| Dec 31, 2022 | 1.45B | -2.57B | -63.89% |
| Dec 31, 2021 | 4.02B | 2.43B | 152.36% |
| Dec 31, 2020 | 1.59B | 819.81M | 105.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Aier Eye Hospital Group | 22.17B |
| Shanghai United Imaging Healthcare | 12.20B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |